Source: World Brazil News

The president of the Federal Council of Medicine (CFM), Mauro Ribeiro, said that the claim that early treatment against covid-19 is ineffective is not true.

The statement was granted on Thursday 25, during the program Jornal da Manhã, of the radio station Jovem Pan.

According to the CFM president, ‘certain matters’ are being prevented.

“Unfortunately, certain subjects have been banned. This story that it is established in the literature that early treatment has no effect in the initial phase is a lie ”, he declared.

When expanding the subject about early treatment, which has been constantly attacked by the press, but defended by thousands of doctors in the country, Ribeiro said that there are, yes, studies that point out benefits of early treatment in the initial phase.

“There are studies that show the benefits [of the therapy] in the initial phase, and others, not. This is the reality. We have a list of jobs,” added the specialist.

According to him, despite the Covid-19 outbreak spreading more than 1 year ago, there are still many doubts about the disease.

Ribeiro made strong criticisms, even, to the document of the Brazilian Medical Association, which was against the use of medicines in the fight against the coronavirus.

“Whoever has a legal assignment in order to define what can or cannot be used is the CFM”, he said.

The President of the Federal Council of Medicine made a point of defending and strengthening the autonomy of health professionals:

What was our stance on early treatment? Letting the doctor define what is best for his patient ”, he maintained, stressing that“ CFM does not encourage early treatment or condemns it, nor does it ban ”.

Finally, Mauro Ribeiro denied the narrative adopted by most media outlets in the country, which insists on associating deaths around Covid-19 with the use of early treatment.

“To say that hydroxychloroquine and ivermectin kill is a fallacy. Who wants to do the early treatment, do it. Whoever doesn’t want it, don’t do it ”, he declared.


Ivermectin for Covid-19: Database of all Ivermectin COVID-19 studies – 35 trials and growing

Malaysia to run trials for 2 drugs in Covid-19 treatment, including Ivermectin

Not Using Ivermectin, One Year In, Is Unethical And Immoral

COVID-19: A realistic approach to community management – HCQ & IVM in concert with vaccination

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »